Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease
Initiation follows successful IND clearance based on preclinical data package indicating robust increase in fetal hemoglobin with no cytotoxicity Novel Globin-Switching... Read more.
LandGateยฎ Releases Q2 2025 Report on Gas Power for Data Centers
DENVER, June 26, 2025 /PRNewswire/ — LandGateยฎ, a trusted provider of data and analytics for energy and technology industries, has published its latest report... Read more.
Prokaryotics Announces Licensing Agreement with Northern Antibiotics for Novel Gram-negative Antibiotic Potentiator
UNION, N.J., June 26, 2025 /PRNewswire/ —ย Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel... Read more.
Millennia Appoints Missy Lane to Lead Client Experience, Renewing Focus on Client Partnerships
CARY, N.C., June 26, 2025 /PRNewswire/ — Millennia, a leader in patient revenue cycle and experience solutions for healthcare providers and hospitals alike,... Read more.
ArDrive Saves All NFT.NYC Artwork on World’s First Permanent Cloud
NEW YORK, June 26, 2025 /PRNewswire/ — Arweave based app ensures all NFT.NYC creations are securely and immutably stored on permanent cloud AR.IO. ArDrive,... Read more.
Cyngn Highlights Next-Generation Robotics, Automation and AI Technologies at Automatica in Collaboration with NVIDIA
MOUNTAIN VIEW, Calif., June 26, 2025 /PRNewswire/ — Cyngn Inc. (Nasdaq: CYN) today announced its collaboration with NVIDIA as part of the Automatica 2025 robotics... Read more.
Schneider Electric Opens Robotics and Motion Center of Excellence in Raleigh
State-of-the-art design and demonstration lab expands Schneider’s Raleigh Hub, focuses on innovations in AI, digitalization, and automation technologies to... Read more.
Nanoscope Therapeutics Propels Patient-Centered Innovation in Inherited Retinal Diseases with New Visionary Advisory Committee
DALLAS, June 26, 2025 /PRNewswire/ — Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies... Read more.
Bit Digital, Inc. Announces Pricing of Public Offering of its Ordinary Shares
NEW YORK, June 26, 2025 /PRNewswire/ — Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”), today announced the pricing... Read more.
Peptone Hosts In-Person Advisory Meeting With Leading Experts in Oncology, Drug Development and Medicinal Chemistry to Advance Small Molecule IDP-Targeted Treatment Solutions
LONDON, June 26, 2025 /PRNewswire/ — Peptone, a biotech company developing novel therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases,... Read more.